Crinetics Pharmaceuticals Inc (CRNX)
EBITDA Margin
-523.08%
Quarterly · Period ending:
CRNX EBITDA Margin
Latest reported-523.08%period ending
Latest reported-523.08%period ending
CRNX Quarterly EBITDA Margin (0.00% → -523.08%)
Quarterly ebitda margin
High-resolution chart · PNG
CRNX ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -523.0751% | |
| -1,180.2217% | |
| -1,974.371% | |
| -90,265.035% | |
| -11,122.9874% | |
| -26,550.9695% | |
| 0% | |
| 0% | |
| -18,371.4286% | |
| -10,383.75% | |
| 0% | |
| -16,527.4566% | |
| -5,131.4777% | |
| -1,706.3083% | |
| -6,306.2059% | |
| -9,099.7817% | |
| -9,603.6446% | |
| -1,098.2753% | |
| -2,834.7866% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |